In this study, we demonstrated that the pathological accumulation of the dopamine catabolite DOPAL in cells, associated to the dopaminergic dysfunction in PD, displays a distinct effect on the scaffold protein p62, leading to an altered proteostasis at different levels. Here, SQSTM1 is linked to Parkinson disease.